MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
ABBVIE INCUS5.48%
AMARIN CORPORATION PLC -ADRGB0.54%
AMERISOURCEBERGEN CORPUS4.93%
ASTRAZENECA PLC-SPONS ADRGB5.21%
BAUSCH HEALTH COS INCCA2.79%
BRISTOL-MYERS SQUIBB COUS5.46%
CATALENT INCUS3.42%
ELANCO ANIMAL HEALTH INCUS3.03%
ELI LILLY & COUS4.86%
GLAXOSMITHKLINE PLC-SPON ADRGB4.62%
JAZZ PHARMACEUTICALS PLCIE2.77%
JOHNSON & JOHNSONUS5.06%
MCKESSON CORPUS4.96%
MERCK & CO. INC.US5.35%
MYLAN NVNL5.13%
NOVARTIS AG-ADRCH5.11%
NOVO-NORDISK A/S-SPONS ADRDK4.13%
ORGANON & COUS2.88%
PATTERSON COMPANIES INCUS0.61%
PERRIGO CO PLCIE1.41%
PFIZER INCUS5.12%
SANOFI-ADRFR5.32%
TAKEDA PHARM-ADRJP4.54%
TEVA PHARMACEUTICAL-SP ADRIL3.56%
ZOETIS INCUS3.71%
Items 1-25 of total 25
Up